Should ReSPonD change falls prevention in Parkinson's disease?
نویسندگان
چکیده
SUMMARY The ReSPonD trial was a single-centre, double-blind, placebo controlled phase 2 trial to investigate whether the acetylcholinesterase inhibitor rivastigmine would reduce gait variability in Parkinson's disease (PD). 1 A total of 130 patients with PD were randomised to receive twice daily oral rivastigmine or placebo for 32 weeks in a 1:1 ratio. Rivastigmine was uptitrated to a target dose of 12 mg per day over 12 weeks. Inclusion criteria were: at least one fall in the preceding year, ability to walk 18 metres without a walking aid, no previous exposure to acetylcholinesterase inhibitors and importantly no dementia or other neurological, orthopaedic or visual problem that interfered with gait. The primary endpoint was the difference in step time variability between the two groups at 32 weeks. Step time variability was measured with a triaxial accelerometer during three different variations of an 18 metre walking task: normal walking, a simple dual task (walking while naming words beginning with a single letter) and a complex dual task (walking while naming words alternating between two letters). At the end of the study period, the treatment arm had a reduction in step time variability of 28% for normal walking (geometric mean 0·72, 95% CI 0·58–0·88; p = 0·002) and 21% in the simple dual task (0·79; 0·62–0·99; p = 0·045). There was a non-significant trend towards improvement for the complex dual task. Adjusted falls incidence rate ratio was considerably lower in the rivastigmine group (0.55, 95% CI 0.38–0.81; p = 0.002). There was a higher incidence of gastrointestinal side effects 52% vs 18% (predominantly nausea) in the rivastigmine group. The authors concluded that rivastigmine can improve gait stability and might reduce falls in patients with PD, necessitating a phase 3 randomised controlled trial with falls as the primary outcome. OPINION Rivastigmine is a licensed treatment for PD dementia, so clinical application in this patient group is already established. The aetiology of falls in PD is multifactorial. Current approaches to falls prevention in PD with exercise-based interventions have had conflicting outcomes when studied in clinical trials, with some evidence supporting Tai Chi. Given the frequency of and morbidity associated with falls in PD, a pharmacological approach to falls prevention is an attractive prospect. Although dopaminergic depletion is the primary deficit and there is some evidence for improvement in gait variability with levodopa use, 6 falls remain common. Cholinergic impairment in PD may be implicated in …
منابع مشابه
Slow Down and Concentrate: Time for a Paradigm Shift in Fall Prevention among People with Parkinson's Disease?
Introduction. We know little about how environmental challenges beyond home exacerbate difficulty moving, leading to falls among people with Parkinson's (PwP). Aims. To survey falls beyond home, identifying challenges amenable to behaviour change. Methods. We distributed 380 questionnaires to PwP in Southern England, asking participants to count and describe falls beyond home in the previous 12...
متن کاملFalls and mobility in Parkinson's disease: protocol for a randomised controlled clinical trial
BACKGROUND Although physical therapy and falls prevention education are argued to reduce falls and disability in people with idiopathic Parkinson's disease, this has not yet been confirmed with a large scale randomised controlled clinical trial. The study will investigate the effects on falls, mobility and quality of life of (i) movement strategy training combined with falls prevention educatio...
متن کاملRecent advances in the assessment and treatment of falls in Parkinson's disease
Falls are among the most incapacitating features of Parkinson's disease. Prevention of falls requires a systematic assessment of all contributing factors (with emphasis on freezing of gait and frontal executive dysfunction), and a multidisciplinary treatment approach tailored to the specific pathophysiology of falls for each individual patient.
متن کاملExercise therapy for prevention of falls in people with Parkinson's disease: A protocol for a randomised controlled trial and economic evaluation
BACKGROUND People with Parkinson's disease are twice as likely to be recurrent fallers compared to other older people. As these falls have devastating consequences, there is an urgent need to identify and test innovative interventions with the potential to reduce falls in people with Parkinson's disease. The main objective of this randomised controlled trial is to determine whether fall rates c...
متن کاملRESPOND--A patient-centred programme to prevent secondary falls in older people presenting to the emergency department with a fall: protocol for a multicentre randomised controlled trial.
INTRODUCTION Participation in falls prevention activities by older people following presentation to the emergency department (ED) with a fall is suboptimal. This randomised controlled trial (RCT) will test the RESPOND programme, an intervention designed to improve older persons' participation in falls prevention activities through delivery of patient-centred education and behaviour change strat...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- The journal of the Royal College of Physicians of Edinburgh
دوره 46 2 شماره
صفحات -
تاریخ انتشار 2016